Le Lézard
Classified in: Covid-19 virus
Subjects: MAV, CFG

Media Advisory - The Vieux Théâtre de Saint-Fabien to Receive Government of Canada Funding for Its Renovation Work


The Honourable Steven Guilbeault, Minister of Canadian Heritage, will make an announcement on Wednesday about the Vieux Théâtre de St-Fabien

SAINT-FABIEN, QC, Aug. 10, 2021 /CNW/ - The Honourable Steven Guilbeault, Minister of Canadian Heritage, will make an announcement on Wednesday about the Vieux Théâtre de St-Fabien. The Minister will take part virtually in the press conference. The other participants will attend in person.

Journalists attending the in-person press conference must not have symptoms similar to COVID-19 or have been in contact with someone who has tested positive in the past 14 days. It is mandatory to wear a mask.

Please note that all details are subject to change. All times are local.

The details are as follows:

DATE: Wednesday August 11, 2021

TIME: Announcement will start at 10:00 a.m.

PLACE: Vieux Théâtre de St-Fabien
112, 1re rue
Saint-Fabien, Quebec

SOURCE Canadian Heritage


These press releases may also interest you

at 07:35
Arrowhead Pharmaceuticals, Inc. announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and...

at 07:35
Fortive Corporation ("Fortive") today announced financial results for the first quarter of 2024. For the first quarter, net earnings were $207 million. For the same period, adjusted net earnings were $295 million, which excludes the $63 million...

at 07:30
Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costsTogether with GSK, ended Pandemic Preparedness Agreement (PPA) with Federal Republic of Germany, after...

at 07:20
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threatStudy will assess monovalent vaccine candidate, encoding an...

at 07:20
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

at 07:05
Healthcare Services Group, Inc. today reported results for the three months ended March 31, 2024. Ted Wahl, Chief Executive Officer, stated, "Our team delivered strong first quarter results, building on our positive momentum in 2023. During the...



News published on and distributed by: